Medical Affairs

By Jacob Presson, Research Analyst In light of the coming American Society for Clinical Oncology (ASCO) annual meeting, many companies are scrambling to get their medical publications out by the conference deadline. One of the biggest contributions...

By Sarah Ray, Research Analyst Drug companies are reaching beyond specialists when targeting medical leaders to further develop their existing products.  Among 36 companies recently surveyed, nearly four-fifths targeted multiple types of key opinion...

Marketing and commercial teams get a lot of the credit for a successful product launch, but medical affairs teams are typically buzzing with activity in the months (sometimes even years) preceding drug approval.  As the official communication channel between a...

Cutting Edge Information recently conducted research among pharmaceutical medical affairs groups that looked at physician-interaction database ownership.  The research revealed that ownership of these databases varies among the surveyed companies.  Global groups...

Drug companies’ increased pharmacovigilance activities highlight the importance of both clinical data and adverse events reporting.  The World Health Organization (WHO) estimates that adverse drug reactions (ADRs) represent between the fourth- and sixth-leading...

Although marketing and market access functions may not support a developing drug until Phase 2 or even later, companies need to coordinate between several different teams as products move through different development stages beginning in the pre-clinical stage....

Within companies’ medical affairs groups, medical information subfunctions disseminate information quickly across consumer and healthcare practitioner audiences alike.  However, US companies rely on different-sized medical information teams to fulfill these...

Regardless of company size, establishing operations to support expansions in new territories has a big impact on existing organizational structures.  The question often rests on how the subsidiary will be connected to the headquarters. Will it be a centralized...

The future of speaker programs has looked murky for the past few years for several reasons: tightened budgets, increased regulatory scrutiny and heightened media attention to speaker fees — as seen in the Dollars for Docs platform and potential CME Sunshine Act...

When France first released its 2011 draft of the Bertrand Act — which included a provision similar to the Sunshine Act here in the US – the legislation promised to be more stringent than US guidelines.  The draft required companies to post its payments on...